Multilingual scores. Cited evidence. Free API.

Stroke risk in non-valvular atrial fibrillation

Stroke risk in atrial fibrillation (2024 ESC, sex-free)

Bleeding risk in patients with atrial fibrillation on anticoagulation

Bleeding risk in atrial fibrillation (validated in the DOAC era)

Symptom classification in atrial fibrillation

Risk stratification for chest pain in the emergency department

In-hospital mortality risk in acute coronary syndrome

14-day death / MI / urgent revascularization risk in UA/NSTEMI

Functional classification of heart failure

ESC 2021 10-year fatal + non-fatal CV event risk (low-risk region).

2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk.

Estimated glomerular filtration rate (eGFR) without race coefficient

Na − (Cl + HCO₃) — screens for high-AG metabolic acidosis (MUDPILES).

Fractional excretion of sodium — separates prerenal from intrinsic AKI.

Estimation of creatinine clearance (CrCl) for drug dose adjustment.

Calculate free water deficit and maximum safe rehydration rate.

Clinical probability of pulmonary embolism

Criteria to rule out pulmonary embolism without further testing

Group A strep pharyngitis probability

Score for acute appendicitis (MANTRELS).

Pre-test probability of deep-vein thrombosis (Wells 2003).

End-stage liver disease severity and transplant priority

Cirrhosis severity and 1-year survival (Pugh 1973).

Pre-endoscopy triage in upper-GI bleeding (Blatchford 2000).

Quick screen for sepsis-related organ dysfunction (Sepsis-3)

Sequential Organ Failure Assessment (Vincent 1996). Sepsis-3 operational definition.

Acute Physiology and Chronic Health Evaluation II (Knaus 1985). ICU severity / mortality.

Community-acquired pneumonia severity

Consciousness level after head injury

National Institutes of Health Stroke Scale (Brott 1989). Acute stroke severity.

Adjust total serum calcium for the patient's albumin level (Payne 1973).

What the sodium would be at a normal glucose level (Katz 1973).

Estimated basal metabolic rate and daily energy needs.

10-year risk of developing type 2 diabetes (Lindström 2003).

Body mass index calculation and WHO cardiometabolic risk categorization.

Body Mass Index, Mosteller/DuBois BSA, Devine IBW and Adjusted Body Weight.

Homeostatic Model Assessment for insulin resistance from fasting glucose and insulin.

PSA divided by prostate volume; helps interpret the grey-zone PSA (4–10 ng/mL).

International Prostate Symptom Score for benign prostatic hyperplasia (Barry 1992).

Age-adjusted comorbidity index predicting 10-year mortality.

Body surface area calculation using the simplified Mosteller formula.

Laboratory Risk Indicator for Necrotising Fasciitis (Wong 2004).

Severity score for bloodstream infections.

Diagnostic criteria for infective endocarditis (Li 2000).

Revised Cardiac Risk Index for non-cardiac surgery.

Anatomical classification of acute complicated diverticulitis (Hinchey 1978).

Venous thromboembolism risk in surgical and medical inpatients (Caprini 2010).

Bedside score for pressure ulcer risk in immobile patients.

Standardised score for pressure ulcer risk in acute care.

10-item assessment of activities of daily living (Mahoney & Barthel 1965).

Bath Ankylosing Spondylitis Disease Activity Index (Garrett 1994).

Disease Activity Score on 28 joints for rheumatoid arthritis (Prevoo 1995).

Psoriasis Area and Severity Index (Fredriksson 1978).

Scoring Atopic Dermatitis (European Task Force 1993).

American Society of Anesthesiologists pre-operative classification (Hurwitz 2017 update).

Newborn physiological assessment at 1 and 5 minutes post-birth.

Patient Health Questionnaire-9 for major depressive disorder screening and severity assessment.

Generalized Anxiety Disorder 7-item scale for screening and severity measurement.

Clinical Institute Withdrawal Assessment for Alcohol, Revised (10 items, max 67).

Clinical Opiate Withdrawal Scale for quantitative opioid withdrawal rating (11 items, max 48).

Clinical triage score for suicide risk assessment and emergency decision-making.

ISTH score for overt DIC in patients with a predisposing disorder.

Pretest probability of HIT from four clinical criteria; low scores rule it out.

VTE risk before chemotherapy, from tumour site and pretreatment labs.

Prognostic staging (A, B, C) by involved lymphoid areas and cytopenias.